Loading stock data…
ZTS
$76.50-6.33 (-7.64%)
Market OpenUpdated 3:43 PM EDT
Zoetis Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Zoetis Inc. in the Healthcare sector is trading at $76.49. The stock is currently near its 52-week low of $76.38, remaining 41.0% below its 200-day moving average. Technical signals show oversold RSI of 6 and bearish MACD signal, explaining why ZTS maintains its current current market pressure. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Oversold momentum (RSI 6) — potential for technical mean-reversion
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$76.50
Potential Upside
74.7%
Whystock Fair Value$133.66
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus17 analysts
Buy
Mean target$136.06+77.8%
Range$95.00 – $185.00
Fundamentals
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the Uni...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$48.99B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
19.28
Beta
Defensive asset. Lower volatility than the S&P 500.
0.97
Div Yield
Strong income play. Yield provides a meaningful total return floor.
183.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
78.41%
Volume
Today's trading volume
12.66M
Recent News
Zoetis Inc. Just Missed Earnings - But Analysts Have Updated Their Models
One of the biggest stories of last week was how Zoetis Inc. ( NYSE:ZTS ) shares plunged 24% in the week since its...
Sector Update: Healthcare Stocks Lower Late Afternoon
Healthcare stocks declined late Friday afternoon, with the NYSE Healthcare Index and the State Stree
Company News for May 8, 2026
Companies in The News Are: MCFT,TNDM,ZTS,BDX
Zoetis (ZTS) Is Down 24.1% After Cutting 2026 Guidance On Softer U.S. Pet Demand – Has The Bull Case Changed?
In early May 2026, Zoetis reported first-quarter 2026 results showing sales of US$2,262 million and net income of US$601 million, with earnings per share rising year on year but missing analyst expectations and prompting a reduction in full-year revenue and earnings guidance. The results revealed a sharp contrast between stronger international and livestock performance and a weaker U.S. companion-animal business, where increased price sensitivity, fewer veterinary visits, and tougher...
Zoetis Inc. Q1 2026 Earnings Call Summary
Moby summary of Zoetis Inc.'s Q1 2026 earnings call